000963 华东医药
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额2,506,4033,929,2172,381,8533,169,7583,411,448
投资活动产生之现金流量净额(1,604,456)(1,750,552)(2,435,598)(1,986,683)(1,738,637)
筹资活动产生之现金流量净额(1,161,417)(1,393,361)(99,710)(767,453)(725,730)
汇率变动对现金及现金等价物的影响21,3645,946(9,775)7,112(21,445)
现金及现金等价物净增加/(减少)(238,106)791,249(163,230)422,734925,636
期初现金及现金等价物余额4,208,1603,416,9113,580,1413,157,4072,231,772
期末现金及现金等价物余额3,970,0544,208,1603,416,9113,580,1413,157,407